Andexxa will go nationwide with FDA nod on Portola's commercial production of the bleeding antidote

Andexxa will go nationwide with FDA nod on Portola's commercial production of the bleeding antidote

Source: 
Fierce Pharma
snippet: 

Portola will finally see the commercial release of its universal bleeding reversal agent Andexxa, a milestone not only for the biotech but also for Pfizer and Bristol-Myers Squibb, as well as Bayer and Johnson & Johnson, whose blood thinners rely on it as a bleeding antidote.